FDA Among Regulatory Authorities Reeling From Brexit Bombshell
This article was originally published in The Tan Sheet
Commissioner Robert Califf says FDA has no firm plan but will “react to whatever happens” following the UK’s momentous decision to leave the EU. The European Medicines Agency also is taking a wait-and-see approach, while regulated industries brace for potential compliance, R&D and IP challenges in Brexit’s aftermath.
Register for our free email digests: